Retatrutide: Primary completion of P3 TRIUMPH-3 trial (NCT05882045) for obesity in Jan 2026 (Eli Lilly) - Feb 6, 2025 - Q4 2024 Results: Completion of P3 TRIUMPH-3 trial for obesity in Feb 2026; Primary completion of P3 TRIUMPH-4 trial (NCT05931367) for obesity in Feb 2026; Completion of P3 TRIUMPH-3 trial for obesity in Mar 2026
Trial completion date • Trial primary completion date • Obesity
|